Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Human mutations in ATRX are linked to cognitive deficits, developmental issues, and cancer.
• ATRX plays a crucial role in maintaining genome stability, particularly at repetitive DNA regions.

Purpose of the Study:

• To investigate the in vivo consequences of ATRX loss in the mouse embryonic brain.
• To elucidate the mechanisms underlying ATRX-associated DNA damage and systemic defects.

Main Methods:

• Generation and analysis of Atrx-null embryonic mouse brains.
• Assessment of DNA damage, telomere integrity, and replication stress response in neuroprogenitors.
• Pharmacological manipulation using G-quadruplex ligands.
• Evaluation of systemic phenotypes and hormonal levels (thyroxine, IGF-1).

Main Results:

• Atrx-null brains accumulate replicative damage at telomeres and pericentromeric heterochromatin, exacerbated by p53 loss and ATM activation.
• ATRX-deficient neuroprogenitors show increased telomere fusions and sensitivity to replication stress.
• Loss of ATRX in the anterior pituitary leads to reduced thyroxine and IGF-1, contributing to systemic defects like growth reduction and shortened lifespan.
• ATRX deficiency causes phenotypes resembling accelerated aging, including bone density loss and fat reduction.

Conclusions:

• Loss of ATRX leads to significant DNA damage and genomic instability in the brain and anterior pituitary.
• ATRX is essential for the replication of G-quadruplex DNA structures at telomeres.
• Defects in the anterior pituitary due to ATRX loss contribute to a spectrum of aging-like systemic phenotypes.